Director
Takeda
Cambridge, Massachusetts
Dr. Sugimoto is the Director at Takeda Development Center Americas Inc., leading preclinical transcriptomic/proteomic biomarker research to support oncology and gastroenterology disease programs. He also served as the nonclinical pharmacokinetics project representative to support the cell therapy program IND submission.
He received a Ph.D. in Pharmaceutical Science from the University of Shizuoka, Japan, and an MBA in Health Sector Management from Boston University. He has been a chair of the Applied Pharmaceutical Analysis (APA) 2024 in Boston, co-chair of the AAPS Gene and Cell Therapy Products biomarker/bioanalytical subteam, and reviewer and mentor for the MassNextGen and Nucleate.
Disclosure information not submitted.
Rapid Fires: Designing and Delivering Effective Clinical Trials for Specific Populations 2
Tuesday, November 11, 2025
3:00 PM - 4:00 PM CT